Medplus Health Services
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
MedPlus Health Services is strategically transitioning towards a capital-efficient growth model, focusing on expanding its franchisee network and enhancing its private label offerings. Management's commitment to increasing the number of stores to 800 by FY27, alongside optimizing supply chain efficiencies, is expected to drive revenue growth and maintain stable margins. The company's emphasis on a robust omni-channel platform and targeted expansion in Tier-Two markets positions it well to capture a larger market share. Vista's financial outlook reflects a stable revenue growth trajectory, with margins expected to remain consistent, supported by the company's debt-free status and operational efficiencies. The retail sector's recovery and improving pricing power further bolster MedPlus's competitive position. However, execution risks related to store management and inventory remain watchpoints. Over the next 12-24 months, key opportunities include the successful rollout of the private label strategy and expansion into new markets, while headwinds may arise from potential supply chain disruptions and competitive pressures in the retail pharmacy landscape
Why We Like This Stock
- Management's aggressive expansion plan to add 800 stores by FY27 supports revenue growth
- Focus on enhancing private label offerings is expected to improve gross margins
- The company's debt-free status provides significant flexibility for future investments
Things To Watch Out For
- Execution risks related to store closures and inventory management could impact performance
- Intense competition in the retail pharmacy sector may pressure market share
- Potential supply chain disruptions could affect product availability and margins
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 5,625 | 6,136 | 6,892 | 7,400 | 8,401 |
| Profit Before Tax (Cr.) | 69 | 177 | 275 | 298 | 338 |
| PBT Margin | 1.2% | 2.9% | 399.0% | 4.0% | 4.0% |
| Net Profit (Cr.) | 44 | 131 | 198 | 215 | 243 |
| Earnings Per Share | 3.6 | 10.9 | 16.5 | 17.9 | 20.2 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| HDFC Securities | ▲ Buy | 1,100 | 22-May-2026 |
Company Overview
Show Company Profile
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.